The Gender-Paradox among patients with implantable cardioverter- defibrillators: A propensity-matched study

PACE - Pacing and Clinical Electrophysiology

Volumn 36, Issue 7, 2013, Pages 878-884

  Bhavnani, Sanjeev P ^a   Pavuluri, Vamsimohan ^a   Coleman, Craig I ^a   Guertin, Danette ^a   Yarlagadda, Ravi K ^a   Clyne, Christopher A ^a   Kluger, Jeffery ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

gender; implantable cardioverter defibrillator; mortality; risk stratification; shocks

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NONISCHEMIC CARDIOMYOPATHY; RETROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT INDICATION;

GENDER; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; MORTALITY; RISK STRATIFICATION; SHOCKS;

AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; PROPENSITY SCORE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84879616516     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12141     Document Type: Article

References (29)

1. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 3: 225-237.
2. The Antiarrhythmic Versus Implantable Cardioverter Defibrillators (AVID). Investigators. A comparison of antiarrhythmic-drug therapy with implantable cardioverter defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al.; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
4. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
5. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, Calkins H, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2154-2158.
6. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, et al.; Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010; 363: 2385-2395.
7. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA,. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA 2007; 298: 1517-1524.
8. Henyan NN, White CM, Gillespie EL, Smith K, Coleman CI, Kluger J,. The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death. J Intern Med 2006; 260: 467-473.
9. Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C,. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: A meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169: 1500-1506.
10. Santangeli P, Pelargonio G, Dello Russo A, Casella M, Bisceglia C, Bartoletti S, Santarelli P, et al. Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: A systematic review and meta-analysis. Heart Rhythm 2010; 7: 876-882.
11. Zareba W, Moss AJ, Jackson Hall W, Wilber DJ, Ruskin JN, McNitt S, Brown M, et al. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol 2005; 16: 1265-1270.
12. Russo AM, Stamato NJ, Lehmann MH, Hafley GE, Lee KL, Pieper K, Buxton AE,. Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial. J Cardiovasc Electrophysiol 2004; 15: 993-998.
13. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP,; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. Ann Intern Med 2007; 147: 573-577.
14. Lampert R, McPherson CA, Clancy JF, Caulin-Glaser TL, Rosenfeld LE, Batsford WP,. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter- defibrillators. J Am Coll Cardiol 2004; 43: 2293-2299.
15. Goldenberg I, Moss AJ, Hall WJ, Foster E, Goldberger JJ, Santucci P, Shinn T, et al.; MADIT-CRT Executive Committee. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 2011; 124: 1527-1536.
16. Linde C, Abraham WT, Gold MR, Daubert C,. Cardiac resynchronization therapy in asymptomatic or mildy symptomatic heart failure patients in relation to etiology: Results from the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) study. J Am Coll Cardiol 2010; 56: 1826-1831.
17. Cheng A, Gold MR, Waggoner AD, Meyer TE, Seth M, Rapkin J, Stein KM, et al. Potential mechanisms underlying the effect of gender on response to cardiac resynchronization therapy: Insights from the SMART-AV Multicenter trial. Heart Rhythm 2012; doi: 10.1016/j.hrthm.2011.12.013
18. Knappe D, Pouleur AC, Shah AM, Cheng S, Uno H, Hall WJ, Bourgoun M, et al. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy. Circ Heart Fail 2011; 4: 433-440.
19. Solomon SD, Foster E, Bourgoun M, Shah A, Viloria E, Brown MW, Hall WJ, et al.; MADIT-CRT Investigators. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: Multicenter automatic defibrillator implantation trial: Cardiac resynchronization therapy. Circulation 2010; 122: 985-992.
20. Wu TJ, Ong JJ, Hwang C, Lee JJ, Fishbein MC, Czer L, Trento A, et al. Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: Role of increased fibrosis in the generation of reentry. J Am Coll Cardiol 1998; 32: 187-196.
21. Gao P, Gula L, Yee R, Krahn AD, Skanes A, Leong-Sit P, Klein GJ, et al. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: Evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging 2012; 5: 448-456.
22. Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ,. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol 2011; 57: 821-828.
23. Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D, Lai S,. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008; 51: 2414-2421.
24. Grün S, Schumm J, Greulich S, Wagner A, Schneider S, Bruder O, Kispert EM, et al. Long-term follow-up of biopsy-proven viral myocarditis: Predictors of mortality and incomplete recovery. J Am Coll Cardiol 2012; 59: 1604-1615.
25. Frazier CG, Alexander KP, Newby LK, Anderson S, Iverson E, Packer M, Cohn J, et al. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: A pooled analysis of 5 randomized control trials. J Am Coll Cardiol 2007; 49: 1450-1458.
26. Bhavnani SP, Kluger J, Coleman CI, White CM, Guertin D, Shafi NA, Yarlagadda RK, et al. The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators. Heart Rhythm 2010; 7: 755-760.
27. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008; 359: 1009-1017.
28. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004; 110: 3760-3765.
29. Albert CM, Quigg R, Saba S, Estes NA 3rd, Shaechter A, Subacius H, Howard A, et al. Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy. Am Heart J 2008; 156: 367-372.